pyxis oncology is developing antibody therapeutics to promote the body's immune response to cancer, based on new insights into the tumor micro-environment.
Company profile
Ticker
PYXS
Exchange
Website
Employees
Incorporated
Location
Fiscal year end
Sector
Industry (SIC)
SEC CIK
Corporate docs
Subsidiaries
Pyxis Securities Corporation • Apexigen, Inc. • Apexigen America Inc. ...
IRS number
831160910
PYXS stock data
Latest filings (excl ownership)
PRE 14A
Preliminary proxy
13 Sep 24
10-Q
2024 Q2
Quarterly report
14 Aug 24
8-K
Pyxis Oncology Provides Corporate Update and Reports Financial Results for Second Quarter 2024
14 Aug 24
8-K
Submission of Matters to a Vote of Security Holders
12 Jun 24
8-K
Pyxis Oncology Expands Board of Directors with Appointment of Michael A. Metzger
10 Jun 24
10-Q
2024 Q1
Quarterly report
14 May 24
8-K
Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024
14 May 24
ARS
2023 FY
Annual report to shareholders
26 Apr 24
DEFA14A
Additional proxy soliciting materials
26 Apr 24
DEF 14A
Definitive proxy
26 Apr 24
Latest ownership filings
Financial summary
Quarter (USD) | Jun 24 | Mar 24 | Dec 23 | Sep 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 26.55 mm | 26.55 mm | 26.55 mm | 26.55 mm | 26.55 mm | 26.55 mm |
Cash burn (monthly) | 964.33 k | 68.67 k | 6.68 mm | 5.73 mm | 1.00 mm | 4.71 mm |
Cash used (since last report) | 2.65 mm | 188.66 k | 18.35 mm | 15.74 mm | 2.75 mm | 12.95 mm |
Cash remaining | 23.90 mm | 26.36 mm | 8.20 mm | 10.80 mm | 23.79 mm | 13.60 mm |
Runway (months of cash) | 24.8 | 383.8 | 1.2 | 1.9 | 23.7 | 2.9 |
Institutional ownership, Q2 2024
76.7% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 86 |
Opened positions | 27 |
Closed positions | 15 |
Increased positions | 20 |
Reduced positions | 19 |
13F shares | Current |
---|---|
Total value | 92.48 bn |
Total shares | 45.57 mm |
Total puts | 5.00 k |
Total calls | 134.09 k |
Total put/call ratio | 0.0 |
Largest owners | Shares | Value |
---|---|---|
PFE Pfizer | 7.03 mm | $19.41 mm |
Deep Track Capital | 4.18 mm | $13.85 bn |
Lara Sullivan | 4.17 mm | $9.22 mm |
Laurion Capital Management | 3.86 mm | $12.78 bn |
Tang Capital Partners | 3.47 mm | $0.00 |
BLK BlackRock | 2.79 mm | $9.22 bn |
World Investments B.V. Bayer | 2.74 mm | $30.08 mm |
Balyasny Asset Management | 2.56 mm | $8.48 bn |
Vanguard | 2.06 mm | $6.82 bn |
Ikarian Capital | 1.66 mm | $5.50 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
10 Jun 24 | Metzger Michael A | Stock Option Common Stock | Grant | Acquire A | No | No | 3.97 | 70,683 | 280.61 k | 70,683 |
7 Jun 24 | Santhosh Palani | Common Stock | Grant | Acquire A | No | No | 0 | 6,000 | 0.00 | 6,000 |
26 Mar 24 | Yanchik Connealy Pamela | Common Stock | Grant | Acquire A | No | No | 0 | 328,710 | 0.00 | 1,110,293 |
26 Mar 24 | Lara Sullivan | Stock Option Common Stock | Grant | Acquire A | No | No | 3.83 | 1,071,242 | 4.10 mm | 1,071,242 |
News
RBC Capital Reiterates Outperform on Pyxis Oncology, Maintains $7 Price Target
19 Sep 24
HC Wainwright & Co. Reiterates Buy on Pyxis Oncology, Maintains $7 Price Target
16 Aug 24
Pyxis Oncology Q2 EPS $(0.29) Misses $(0.28) Estimate
14 Aug 24
Stifel Initiates Coverage On Pyxis Oncology with Buy Rating, Announces Price Target of $10
8 Aug 24